| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.99.4.505 |
| P698 | PubMed publication ID | 9927396 |
| P50 | author | Daniel Zakhary | Q73157394 |
| P2093 | author name string | Bond M | |
| Moravec CS | |||
| Stewart RW | |||
| P433 | issue | 4 | |
| P921 | main subject | dilated cardiomyopathy | Q283656 |
| P304 | page(s) | 505-510 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Protein kinase A (PKA)-dependent troponin-I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy | |
| P478 | volume | 99 |
| Q35588197 | 10,000-fold concentration increase in proteins in a cascade microchip using anionic ITP by a 3-D numerical simulation with experimental results |
| Q35786165 | 10,000-fold concentration increase of the biomarker cardiac troponin I in a reducing union microfluidic chip using cationic isotachophoresis |
| Q55092208 | 17β-Estradiol and/or estrogen receptor alpha signaling blocks protein phosphatase 1 mediated ISO induced cardiac hypertrophy. |
| Q36699259 | 2-Deoxyadenosine triphosphate restores the contractile function of cardiac myofibril from adult dogs with naturally occurring dilated cardiomyopathy |
| Q35879498 | A-kinase anchoring protein targeting of protein kinase A in the heart |
| Q36003703 | AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function. |
| Q34982964 | Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice |
| Q36649084 | Alpha1 catalytic subunit of AMPK modulates contractile function of cardiomyocytes through phosphorylation of troponin I. |
| Q44195104 | An epsilonPKC-selective inhibitor attenuates back phosphorylation of a low molecular weight protein in cardiac myocytes |
| Q38248672 | Anchored protein kinase A signalling in cardiac cellular electrophysiology |
| Q58614496 | Assessment of PKA and PKC inhibitors on force and kinetics of non-failing and failing human myocardium |
| Q35315109 | Biochemical and myofilament responses of the right ventricle to severe pulmonary hypertension |
| Q42264504 | Cardiac troponin I tyrosine 26 phosphorylation decreases myofilament Ca2+ sensitivity and accelerates deactivation. |
| Q24300805 | Cardiac troponin T isoforms affect the Ca2+ sensitivity and inhibition of force development. Insights into the role of troponin T isoforms in the heart |
| Q73157396 | Cyclic AMP-dependent protein kinase binding to A-kinase anchoring proteins in living cells by fluorescence resonance energy transfer of green fluorescent protein fusion proteins |
| Q36176071 | Development of dilated cardiomyopathy in Bmal1-deficient mice |
| Q42123152 | Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis. |
| Q28512782 | Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice |
| Q34578568 | Electrical and structural remodeling of the failing ventricle |
| Q33622017 | FRET biosensor uncovers cAMP nano-domains at β-adrenergic targets that dictate precise tuning of cardiac contractility |
| Q41265608 | Force relaxation and thin filament protein phosphorylation during acute myocardial ischemia |
| Q36369931 | Functional consequences of sarcomeric protein abnormalities in failing myocardium |
| Q21129229 | Gene regulation, alternative splicing, and posttranslational modification of troponin subunits in cardiac development and adaptation: a focused review |
| Q33396365 | Genomic selection of reference genes for real-time PCR in human myocardium |
| Q37427881 | Human heart failure is accompanied by altered protein kinase A subunit expression and post-translational state |
| Q34628879 | Maternal diet-induced obesity programs cardiovascular dysfunction in adult male mouse offspring independent of current body weight |
| Q33748197 | Mice lacking the Cβ subunit of PKA are resistant to angiotensin II-induced cardiac hypertrophy and dysfunction |
| Q43919870 | Molecular mechanisms of reduced sarcoplasmic reticulum Ca(2+) uptake in human failing left ventricular myocardium |
| Q39785961 | Molecular mechanisms of sarcomere dysfunction in dilated and hypertrophic cardiomyopathy |
| Q30049005 | Multiple Reaction Monitoring to Identify Site-Specific Troponin I Phosphorylated Residues in the Failing Human Heart |
| Q36593277 | Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies |
| Q44263809 | Myofibrillar responsiveness to cAMP, PKA, and caffeine in an animal model of heart failure |
| Q37503779 | Myofilament Calcium Sensitivity: Mechanistic Insight into TnI Ser-23/24 and Ser-150 Phosphorylation Integration |
| Q34727604 | Pathophysiological basis and clinical application of T-wave alternans |
| Q35600289 | Preconcentration and detection of the phosphorylated forms of cardiac troponin I in a cascade microchip by cationic isotachophoresis |
| Q33678033 | Protein Kinases as Drug Development Targets for Heart Disease Therapy |
| Q79138553 | Protein kinase A dependent phosphorylation activates Mg2+ efflux in the basolateral region of the liver |
| Q33896774 | Protein kinase A is a target for aging and the aging heart |
| Q33641335 | Reduced force production during low blood flow to the heart correlates with altered troponin I phosphorylation |
| Q43876768 | Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity |
| Q46600650 | Reduced troponin I phosphorylation and increased Ca(2+)-dependent ATP-consumption in triton X-skinned fiber preparations from Galphaq overexpressor mice |
| Q33538026 | Regulation of fibre contraction in a rat model of myocardial ischemia |
| Q28295123 | Removal of the N-terminal extension of cardiac troponin I as a functional compensation for impaired myocardial beta-adrenergic signaling |
| Q54578401 | Reorganized PKA-AKAP associations in the failing human heart. |
| Q64114940 | Role of β-adrenergic signaling in masseter muscle |
| Q37200169 | Sarcomere length dependence of power output is increased after PKA treatment in rat cardiac myocytes |
| Q102053331 | Selective changes in cytosolic β-adrenergic cAMP signals and L-type Calcium Channel regulation by Phosphodiesterases during cardiac hypertrophy |
| Q30380968 | TNNI1, TNNI2 and TNNI3: Evolution, regulation, and protein structure-function relationships. |
| Q40243911 | The contributions of cardiac myosin binding protein C and troponin I phosphorylation to β-adrenergic enhancement of in vivo cardiac function |
| Q30476199 | The gene expression fingerprint of human heart failure |
| Q37239549 | The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy |
| Q79325476 | Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure |
| Q34281889 | Type 1 phosphatase, a negative regulator of cardiac function |
| Q85203592 | WITHDRAWN: Simvastatin prevents decreased SERCA2a activity in non-ischemic heart failure in rabbits via inhibition of β-adrenergic signaling |
Search more.